Article Details

Approval Of First Interchangeable Biosimilar, Semglee, Is Sign Of An Improving US Biosimilars ...

Retrieved on: 2021-08-01 17:37:30

Tags for this article:

Click the tags to see associated articles and topics

Approval Of First Interchangeable Biosimilar, Semglee, Is Sign Of An Improving US Biosimilars .... View article details on HISWAI: https://www.forbes.com/sites/joshuacohen/2021/08/01/approval-of-first-interchangeable-biosimilar-semglee-is-sign-of-an-improving-us-biosimilars-market-despite-challenges/

Excerpt

Analysts from Morgan Stanley project a growing U.S. biosimilar market, with $8.6 billion in sales in 2025. But, will Morgan Stanley's projection hold up?

Article found on: www.forbes.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up